Rad-molGPA index is prognostic for non-small cell lung cancer patients with brain metastases. The updated Rad-molGPA incorporating radiomics features into the Lung-molGPA is a user-friendly tool to facilitate clinical decision making and appropriate stratification of future clinical trials.
No takes yet. Share an insight, caveat, or question.
He et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: